1. S100A11 regulates renal carcinoma cell proliferation, invasion, and migration via the EGFR/Akt signaling pathway and E-cadherin
   Lin Liu et al, 2017, Tumour Biol. CrossRef
2. S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma
   Meixia Zhang et al, 2018, Future Oncology CrossRef
3. S100B as an Antagonist To Interfere with the Interface Area Flanked by S100A11 and RAGE V Domain
   Deepu Dowarha et al, 2018, ACS Omega CrossRef
4. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma
   Mei-xia Zhang et al, 2018, Molecular Carcinogenesis CrossRef
5. S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine
   Claus W. Heizmann, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
6. null
   Claus W. Heizmann, 2019 CrossRef
7. Prognostic values of S100 family mRNA expression in ovarian cancer
   Nan Ma et al, 2019, CBM CrossRef
8. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
   Yiming Tu et al, 2019, J Cell Mol Med CrossRef
9. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation
   Yen-Kai Huang et al, 2016, J. Biol. Chem. CrossRef
10. Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer
    Vivian Delcourt et al, 2017, EBioMedicine CrossRef
11. null
    Gopalkrishna Sreejit et al, 2020 CrossRef
12. S100A11 promotes human pancreatic cancer PANC‑1 cell proliferation and is involved in the PI3K/AKT signaling pathway
    Mingbing Xiao et al, 2017, Oncol Lett CrossRef
13. EZH2 knockdown in tamoxifen-resistant MCF-7 cells unravels novel targets for regaining sensitivity towards tamoxifen
    Kanchan Kumari et al, 2020, Breast Cancer CrossRef
14. Expression of S100A11 is a Prognostic Factor for Disease-free Survival and Overall Survival in Patients With High-grade Serous Ovarian Cancer.
    Yanli Li et al, 2017, Appl Immunohistochem Mol Morphol CrossRef
15. Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance
    Wenjing Li et al, 2021, BioMed Research International CrossRef
16. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis
    Haopeng Wang et al, 2021, Technol Cancer Res Treat CrossRef
17. Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer
    Yuxin Cui et al, 2021, Cancer Cell Int CrossRef
18. The Calcium Binding Protein S100A11 and Its Roles in Diseases
    Linqiang Zhang et al, 2021, Front. Cell Dev. Biol. CrossRef
19. A Novel S100 Family-Based Signature Associated with Prognosis and Immune Microenvironment in Glioma
    Yifang Hu et al, 2021, Journal of Oncology CrossRef
20. Circular RNA FOXP1 relieves trophoblastic cell dysfunction in recurrent pregnancy loss via the miR-143-3p/S100A11 cascade
    Yuan Gao et al, 2021, Bioengineered CrossRef
21. Role of Nucleolin in Endometrial Precancerous Hyperplasia and Carcinogenesis: Ex Vivo and In Silico Study
    Vanya D. Barzilova et al, 2022, IJMS CrossRef
22. Mass spectrometry imaging in gynecological cancers: the best is yet to come
    Dagmara Pietkiewicz et al, 2022, Cancer Cell Int CrossRef
23. A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
    Corina E. Antal et al, 2023, Nat Commun CrossRef
24. Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer
    Diala F. Hamade et al, 2024, Cancers CrossRef